FDA-Approved Biosimilar Insulin

Zarxio (Filgrastim-sndz): The First Biosimilar Approved by the FDA.

Zarxio (filgrastim-sndz), a biosimilar for the treatment of severe chronic neutropenia.

FDA-Approved Drugs to Treat Schizophrenia.

FDA-approved medications that impair human spermatogenesis

We herein provide an overview of the single-ingredient U.S. Food and Drug Administration (FDA)-approved drugs that affect human spermatogenesis, potentially resulting in a negative impact on male fertility. To provide this information, we performed an in-depth search of DailyMed, the official website for FDA-approved drug labels. Not surprisingly, hormone-based agents were found to be the drugs...

FDA approved drugs as potential Ebola treatments

In the search for treatments for the Ebola Virus, multiple screens of FDA drugs have led to the identification of several with promising in vitro activity. These compounds were not originally developed as antivirals and some have been further tested in mouse in vivo models. We put forward the opinion that some of these drugs could be evaluated further and move into the clinic as they are alread...

Conflicting Opinions Flood FDA on Its Proposal for Biosimilar Naming.

FDA deluged with opinions on biosimilar naming plans.